The paper by Zerai Woldehiwet, published in this issue of The Veterinary Journal, reviews mechanisms of immune evasion and immune suppression by the mammalian pathogen, Anaplasma phagocytophilum, which primarily invades and replicates within neutrophils. A. phagocytophilum infection causes a generalized immune suppression in sheep characterized by neutropenia, lymphopenia, and susceptibility to various concurrent bacterial infections resulting from impaired neutrophil and lymphocyte function (Woldehiwet, 2007). The related cattle pathogen, A. marginale, which invades and replicates within erythrocytes, causes anemia, abortion in pregnant heifers, and weight loss, can, during acute infection, reach levels of 10 9 infected erythrocytes per milliliter of blood . Following resolution of acute infection, both pathogens establish persistence, which for A. marginale infected cattle, can be of lifelong duration.Both pathogens evade the immune response through antigenic variation of surface coat proteins, including major surface protein (MSP) 2 and MSP3 in A. marginale, and the related MSP2/P44 in A. phagocytophilum (Palmer et al., 2006). The immunological consequences of this antigenic variation have been documented for A. marginale. During persistent infection, organisms express sequentially variant B cell and T cell epitopes in MSP2 that evade effector IgG2 and CD4 + T cell recognition (French et al., 1999;Brown et al., 2003).In contrast to the generalized immune suppression observed during A. phagocytophilum infection of sheep, infection of cattle with A. marginale does not result in altered numbers of circulating leukocytes, including lymphocytes, and generalized immune suppression has not been reported. However, immunization models using A. marginale MSPs have recently revealed infection-induced regulation of a strong pre-challenge CD4 + T cell response. In the first model, cattle were hyperimmunized by subcutaneous inoculation of gel-purified native MSP2 in Th1 adjuvants and challenged 6 months later with organisms expressing the same major MSP2 variant that was present in the immunogen (Abbott et al., 2005). The predicted protection against infection with organisms expressing this major MSP2 variant was not realized; rather the lack of protection against anemia and rickettsemia was accompanied by a dramatic loss in MSP2-specific CD4 + T cell responses. The robust pre-challenge levels of CD4 + T cell proliferation and IFN-g secreting cells in response to A. marginale, native MSP2, or immunogenic MSP2 peptides in both conserved and hypervariable regions were reduced to background levels just prior to peak rickettsemia. The loss of response to epitopes conserved in all MSP2 variant proteins indicated that the loss of the MSP2-specific response was not due to emergence of new antigenic variants. Importantly, antigen-specific responses were never Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers